Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Lumen Technologies Inc (LUMN) vs Twist Bioscience Corp (TWST) Price & Performance

Lumen Technologies IncTrade
Twist Bioscience CorpTrade

Price performance (Past 24H)

Key statistics

Lumen Technologies Inc vs Twist Bioscience Corp — how do they compare? Lumen Technologies Inc trades at $6.69 (market cap $6.47B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: Lumen Technologies Inc is the larger of the two by market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Lumen Technologies Inc nearer its low. Which is the better fit depends on your goals.

LUMNTWST
Market Cap
$6.47B$5.45B
Sector
MediaHealth
52-Week High
$11.83$102.88
52-Week Low
$3.70$24.16
Enterprise Value
$18.10B$5.37B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Lumen Technologies Inc

With 450,000 route miles of fiber, including over 35,000 route miles of subsea fiber connecting Europe, Asia, and Latin America, Lumen Technologies is one of the United States' largest telecommunications carriers serving global enterprises. Its merger with Level 3 further shifted the company's operations toward businesses (over 70% of revenue) and away from its legacy consumer business. Lumen offers businesses a full menu of communications services, providing colocation and data center services, data transportation, and end-user phone and internet service. On the consumer side, Lumen provides broadband and phone service across 37 states, where it has 4.5 million broadband customers.

Read more on LUMN

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.

Read more on TWST